Prolonged versus standard native E. coli asparaginase therapy in childhood acute lymphoblastic leukemia and non-Hodgkin lymphoma: final results of the EORTC-CLG randomized phase III trial 58951

Asparaginase is an essential component of combination chemotherapy for childhood acute lymphoblastic leukemia and non-Hodgkin lymphoma. The value of asparaginase was further addressed in a group of non-very high-risk patients by comparing prolonged (long-asparaginase) versus standard (short-asparagi...

Descripción completa

Detalles Bibliográficos
Autores principales: Mondelaers, Veerle, Suciu, Stefan, De Moerloose, Barbara, Ferster, Alina, Mazingue, Françoise, Plat, Geneviève, Yakouben, Karima, Uyttebroeck, Anne, Lutz, Patrick, Costa, Vitor, Sirvent, Nicolas, Plouvier, Emmanuel, Munzer, Martine, Poirée, Maryline, Minckes, Odile, Millot, Frédéric, Plantaz, Dominique, Maes, Philip, Hoyoux, Claire, Cavé, Hélène, Rohrlich, Pierre, Bertrand, Yves, Benoit, Yves
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Ferrata Storti Foundation 2017
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5622857/
https://www.ncbi.nlm.nih.gov/pubmed/28751566
http://dx.doi.org/10.3324/haematol.2017.165845

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5622857/
https://www.ncbi.nlm.nih.gov/pubmed/28751566
http://dx.doi.org/10.3324/haematol.2017.165845

Ejemplares similares